# Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

> **NCT07435701** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 29 (estimated)

## Conditions studied

- Ovarian Neoplasms Malignant
- Ascites

## Interventions

- **BIOLOGICAL:** SK-NK Cell Injection

## Key facts

- **NCT ID:** NCT07435701
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2026-01-23
- **Final completion:** 2026-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435701, "Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07435701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*